A yeast-like strain was isolated from the brain abscess of a patient diagnosed with astrocytoma. Morphological and molecular analysis on D1/D2 domain in the 26S rRNA gene and internal transcript spacer region of the strain revealed that the strain belonged to the genus Pseudozyma. To the best of our knowledge, this is the first report on the isolation of a Pseudozyma strain from brain abscess. (Korean J Lab Med 2010;30:284-8) 
INTRODUCTION
The Pseudozyma species are ustilaginomycetous yeasts and usually isolated from plants [1, 2] . Thus far, there are only 2 reports on the isolation of Pseudozyma strains from clinical specimens obtained from blood and central venous catheter [2, 3] . Recently, a yeast-like strain was isolated from a cerebral abscess sample, which was obtained from the operation room, of a patient diagnosed with astrocytoma. Morphologic and molecular analyses of the isolate revealed that it belonged to the genus Pseudozyma. Herein, we present the first report on the isolation of Pseudozyma strain from a cerebral abscess.
CASE REPORT
A 78-yr-old male presented to a tertiary hospital with complaints of weakness in his right leg lasting for 2 months. Magnetic resonance imaging (MRI) revealed a 2 cm mass in the left frontal lobe. On hospital day 7, a stereotactic brain biopsy examination was performed, and pathological diagnosis suggested anaplastic astrocytoma. On hospital day 20, fever developed as high as 37.9℃. Blood analysis showed elevated white blood cell counts of 26,390/mL with 93.6% neutrophils and elevated C-reactive protein level of 23.8 mg/dL. We obtained 3 pairs of blood samples for microbial examination. After 3 days of incubation with BacT/Alert 3D system (bioMe@ ieux, Durham, NC, USA), methicillin-resistant Staphylococcus aureus (MRSA) were detected in both of aerobic and anaerobic cultures. Intravenous (IV) vancomycin treatment was started. On hospital day 21, i.e., 14 days after brain biopsy, MRI study revealed a cerebral abscess at the biopsy site. On hospital day 22, the abscess was surgically removed in the operation room and the pus was Phylogenetic trees were constructed using Clustal X software, and the species deduced from the ITS and D1/D2 region sequence data was confirmed [6] . Phylogenetic analysis was conducted by using the neighbor-joining method and bootstrap analysis was performed [7, 8] . The
TreeView program (http://taxonomy.zoology.gla.ac.uk/ rod/treeview.html) was used to view the phylogenetic trees.
Strain YCM09/6/F44 exhibited the highest sequence similarity with Pseudozyma sequences (Fig. 2) . removal [3] . However, there is very limited information on the clinical significance of Pseudozyma strains due to the paucity of reported cases, especially when the strain is isolated from sterile specimens other than blood [2, 3] .
In our study, the pathogenicity of the Pseudozyma strain remains obscure because of the complicated conditions accompanied by underlying malignancy and co-isolation of MRSA; however, it can be predicted that coinfection with the fungus probably contributed to the worsening of the patient' s clinical status.
Interestingly, the species could not be identified by using the YBC card (bioMe@ rieux). There is limited understanding of rare yeasts, including Pseudozyma strains, and the improvements in this field have been slow because of the difficult identification procedures [4] . Molecular methods might be very useful for detecting these rare yeasts, including Pseudozyma strains [2, 17] . In the CLSI guidelines [17] , there were no recommended primers designed specifically to identify Pseudozyma species. For the Ustilago species, a close relative of Pseudozyma species, ITS region is presented as a useful target for species identification [17] . In this study, we sequenced both ITS region and D1/D2 domain, as recommended in previous reports [4, 5] , and obtained satisfactory results.
Similar to other related studies [2, 3] , we could not identify the infection source in our case. We hypothesized that the fungi probably entered during needle biopsy. The increasing number of immunocompromised patients has broadened the spectrum of yeast-related diseases [2] .
Nonetheless, the pathogenicity of yeasts and their association with human diseases are yet to be determined [2, 3] . Therefore, further studies are required to understand the role of pathogenic yeasts. To the best of our knowledge, this is the first report on the isolation of a Pseudozyma strain from cerebral abscess and the third one on isolation from a clinical specimen.
